Below are the most recent publications written about "Lung Neoplasms" by people in Profiles.
-
Betti MJ, Jaworski J, Zhao S, Rao JS, Ryan BM, Schwartz AG, Lusk CM, McCoy L, Wiencke JK, Bruce MA, Chanock S, Gamazon ER, Hellwege JN, Aldrich MC. Genetic analysis in African ancestry populations reveals genetic contributors to lung cancer susceptibility. Am J Hum Genet. 2025 Sep 04; 112(9):2102-2114.
-
Gao Z, Nasu M, Devendra G, Abdul-Ghani AA, Herrera AJ, Borgia JA, Seder CW, Kuehu DL, Feng Z, Chen Y, Gong T, Zhang Z, Chan O, Yang H, Yu J, Fu Y, Wu L, Deng Y. A robust machine learning model based on ribosomal-subunit-derived piRNAs for diagnostic potential of nonsmall cell lung cancer across multicentre, large-scale of sequencing data. Clin Transl Med. 2025 Aug; 15(8):e70418.
-
Byun J, Han Y, Choi J, Sun R, Shaw VR, Zhu C, Xiao X, Lusk C, Badr H, Lee HS, Jang HJ, Li Y, Lim H, Long E, Liu Y, Kachuri L, Walsh KM, Wiencke JK, Albanes D, Lam S, Tardon A, Neuhouser ML, Barnett MJ, Chen C, Bojesen S, Brenner H, Landi MT, Johansson M, Risch A, Wichmann HE, Bickeb?ller H, Christiani DC, Rennert G, Arnold S, Field JK, Shete S, Le Marchand L, Liu G, Andrew AS, Zienolddiny S, Grankvist K, Johansson M, Caporaso N, Taylor F, Lazarus P, Schabath MB, Aldrich MC, Patel A, Lin X, Zanetti KA, Harris CC, Chanock S, McKay J, Schwartz AG, Hung RJ, Amos CI. Genome-wide association study for lung cancer in 6531 African Americans reveals new susceptibility loci. Hum Mol Genet. 2025 Jul 03; 34(14):1227-1237.
-
Xiao Y, Zou X, Tribby CP, Vien P, Chang C, Curley RJ, Akande O, Aldrich MC, Wang S, Kittles RA, Ashing K, Wong FL, Jankowska MM, Benmarhnia T, Erhunmwunsee L. Residential Segregation and Lung Cancer Risk in African American Adults. JAMA Netw Open. 2025 07 01; 8(7):e2518481.
-
Carbone M, Minaai M, Kittaneh M, Krausz T, Miettinen MM, Pan Hammarstr?m Q, Hammarstr?m L, Abolhassani H, Pagano I, Xu R, Novelli F, Gaudino G, Pastorino S, Sarin KY, Ripley RT, Pass HI, Schrump DS, Yang H. Clinical and Pathologic Phenotyping of Mesotheliomas Developing in Carriers of Germline BAP1 Mutations. J Thorac Oncol. 2025 Nov; 20(11):1683-1698.
-
Dela Cruz MC, Yao X, Roberts N, Iheukwumere P, Carmouche A, Medina PM, Biliran H. TLE1 drives EGFR-TKI resistance in EGFR-mutant lung adenocarcinoma through epithelial to mesenchymal transition. Biochem Biophys Res Commun. 2025 Aug 15; 775:152146.
-
Hernandez M, Rogova A, Reitzel LR, Lowenstein LM, Volk RJ. Cigarette Use, Lung Cancer Screening Eligibility and Completion Among Persons With Poor Mental Health. Cancer Med. 2025 Jun; 14(11):e70983.
-
Arshad S, Akinyemi OA, Fasokun M, Cornwell EE, Levy G. The Impact of the Affordable Care Act on Lung Cancer Stage at Presentation. Am Surg. 2025 Jul; 91(7):1086-1092.
-
Lockbaum GJ, Lynes MM, Shen SA, Liu J, Holt N, Nayak SP, Knockenhauer KE, Yao S, Sickmier EA, Raman A, Wu J, Case A, Shehaj L, Buker SM, Grigoriu S, Ribich S, Blakemore SJ, Sparling BA, Duncan KW, Copeland RA, Silver SJ, Boriack-Sjodin PA. Characterization of exoribonuclease XRN1 as a cancer target and identification of adenosine-3',5'-bisphosphate as a potent enzyme inhibitor. Commun Biol. 2025 Apr 09; 8(1):589.
-
Nathani A, Sun L, Li Y, Lazarte J, Aare M, Singh M. Targeting EGFR-TKI resistance in lung cancer: Role of miR-5193/miR-149-5p loaded NK-EVs and Carboplatin combination. Int J Pharm. 2025 Apr 30; 675:125573.